12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Company News  |  Deals

Stem Cell Therapeutics, University of York deal

The university granted Stem Cell Therapeutics an option to license exclusive, worldwide rights to a series of patents covering several potential prostate cancer stem cell targets. The company, which said the targets...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >